Association of hematocrit with blood pressure and hypertension

Journal of Clinical Laboratory Analysis

Volumn 31, Issue 6, 2017, Pages

  Emamian, Marzieh ^a   Hasanian, Seyed Mahdi ^a   Tayefi, Maryam ^a,b   Bijari, Moniba ^a   Movahedian far, Faeze ^a   Shafiee, Mojtaba ^a   Avan, Amir ^a   Heidari Bakavoli, Alireza ^c   Moohebati, Mohsen ^c   Ebrahimi, Mahmoud ^c   Darroudi, Sousan ^a   Zamani, Parvin ^a   Azarpazhooh, Mahmoud Reza ^c   Nematy, Mohsen ^a   Safarian, Mohammad ^a   Ferns, Gordon A ^d   Esmaeili, Habibollah ^b   Parizadeh, Mohammad Reza ^a   Ghayour Mobarhan, Majid ^a,c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

biochemical risk factors; cardiovascular diseases; hematological parameters; hypertension

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER; CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PROTEIN BLOOD LEVEL; RED BLOOD CELL DISTRIBUTION WIDTH; RISK ASSESSMENT; RISK FACTOR; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; BIOMARKERS; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; FEMALE; HEMATOCRIT; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; URIC ACID;

EID: 85010905766     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.22124     Document Type: Article

References (47)

1. Smith SC, Blair SN, Bonow RO, et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2001;38:1581–1583.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217–223.
3. Sander GE, Giles TD. Hypertension and lipids: lipid factors in the hypertension syndrome. Curr Hypertens Rep. 2002;4:458–463.
4. Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension. 2006;47:45–50.
5. Kostis JB. The importance of managing hypertension and dyslipidemia to decrease cardiovascular disease. Cardiovasc Drugs Ther. 2007;21:297–309.
6. Kawada T, Morihashi M, Ueda H, Sirato T. Neutrophil cell count is related to hypertension in workers: a cross-sectional study. Vasc Dis Prev. 2007;4:225–228.
7. Orakzai R, Orakzai S, Nasir K, et al. Association of white blood cell count with systolic blood pressure within the normotensive range. J Hum Hypertens. 2006;20:341–347.
8. Shankar A, Klein BE, Klein R. Relationship between white blood cell count and incident hypertension. Am J Hypertens. 2004;17:233–239.
9. Fici F, Celik T, Balta S, et al. Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension. J Cardiovasc Pharmacol. 2013;62:388–393.
10. Jae SY, Kurl S, Laukkanen JA, et al. Higher blood hematocrit predicts hypertension in men. J Hypertens. 2014;32:245–250.
11. Liu X, Liang J, Qiu Q, et al. Association of hematocrit and pre-hypertension among Chinese adults: the CRC study. Cell Biochem Biophys. 2015;71:1123–1128.
12. Paul L, Jeemon P, Hewitt J, et al. Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults. Hypertension. 2012;60:631–638.
13. Atsma F, Veldhuizen I, de Kort W, van Kraaij M, Pasker-de Jong P, Deinum J. Hemoglobin level is positively associated with blood pressure in a large cohort of healthy individuals. Hypertension 2012;60:936–941.
14. Lee SG, Rim JH, Kim JH. Association of hemoglobin levels with blood pressure and hypertension in a large population-based study: the Korea National Health and Nutrition Examination Surveys 2008-2011. Clin Chim Acta. 2015;438:12–18.
15. Ghayour-Mobarhan M, Moohebati M, Esmaily H, et al. Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: design, baseline characteristics and 10-year cardiovascular risk estimation. Int J Public Health. 2015;60:561–572.
16. Zomorrodian D, Khajavi-Rad A, Avan A, et al. Metabolic syndrome components as markers to prognosticate the risk of developing chronic kidney disease: evidence-based study with 6492 individuals. J Epidemiol Community Health 2015;69:594–598.
17. Emamian M, Avan A, Pasdar A, et al. The lipoprotein lipase S447X and cholesteryl ester transfer protein rs5882 polymorphisms and their relationship with lipid profile in human serum of obese individuals. Gene. 2015;558:195–199.
18. Mirhafez SR, Zarifian A, Ebrahimi M, et al. Relationship between serum cytokine and growth factor concentrations and coronary artery disease. Clin Biochem. 2015;48:575–580.
19. Mirhafez SR, Pasdar A, Avan A, et al. Cytokine and growth factor profiling in patients with the metabolic syndrome. Br J Nutr. 2015;113:1911–1919.
20. Mardan-Nika M, Pasdar A, Jamialahmadi K, et al. Association of heat shock protein70-2 (HSP70-2) gene polymorphism with obesity. Ann Hum Biol 2016;43:542–546.
21. Tripolino C, Gnasso A, Carallo C, Scavelli FB, Irace C. Hemorheological profiles of subjects with prehypertension. Hypertens Res 2016;39:519–523.
22. Cirillo M, Laurenzi M, Trevisan M, Stamler J. Hematocrit, blood pressure, and hypertension. The Gubbio Population Study. Hypertension. 1992;20:319–326.
23. Nakanishi N, Yoshida H, Okamoto M, et al. Hematocrit and risk for hypertension in middle-aged Japanese male office workers. Ind Health. 2001;39:17–20.
24. Vázquez BS, Vázquez MS, Intaglietta M, De Faire U, Fagrell B, Cabrales P. Hematocrit and mean arterial blood pressure in pre-and postmenopause women. Vasc Health Risk Manag. 2009;5:483–488.
25. Kawamoto R, Tabara Y, Kohara K, et al. Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons. Endocrine. 2013;43:334–341.
26. Zeng C, Wei J, Yang T, et al. Higher blood hematocrit predicts hyperuricemia: a prospective study of 62897 person-years of follow-up. Sci Rep 2015;5:13765.
27. Wu S, Lin H, Zhang C, et al. Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. BMC public health. 2013;13:989.
28. Babu KR, Solepure A, Shaikh R. Comparison of hematological parameters in primary hypertensives and normotensives of Sangareddy. Int J Biomed Res. 2015;6:309–315.
29. Cabrales P, Han G, Nacharaju P, Friedman AJ, Friedman JM. Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide. Am J Physiol Heart Circ Physiol. 2011;300:H49–H56.
30. Haltmayer M, Mueller T, Luft C, Poelz W, Haidinger D. Erythrocyte mean corpuscular volume associated with severity of peripheral arterial disease: an angiographic evaluation. Ann Vasc Surg. 2002;16:474–479.
31. Karabulut A, Karadag A. Clinical implication of hematological indices in the essential hypertension. World J Hypertens. 2015;5:93–97.
32. Persson SU, Gustavsson CG, Larsson H, Persson S. Studies on blood rheology in patients with primary pulmonary hypertension. Angiology. 1991;42:836–842.
33. Sharp DS, Curb JD, Schatz IJ, et al. Mean red cell volume as a correlate of blood pressure. Circulation. 1996;93:1677–1684.
34. Nakanishi N, Sato M, Shirai K, Suzuki K, Tatara K. White blood cell count as a risk factor for hypertension; a study of Japanese male office workers. J Hypertens. 2002;20:851–857.
35. Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol. 2001;54:316–322.
36. Cavusoglu E, Chopra V, Gupta A, et al. Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol. 2010;141:141–146.
37. Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med. 2009;169:588–594.
38. Özcan F, Turak O, Durak A, et al. Red cell distribution width and inflammation in patients with non-dipper hypertension. Blood Press. 2013;22:80–85.
39. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117:163–168.
40. Abul Y, Ozsu S, Korkmaz A, Bulbul Y, Orem A, Ozlu T. Red cell distribution width: a new predictor for chronic thromboembolic pulmonary hypertension after pulmonary embolism. Chron Respir Dis. 2014;11:73–81.
41. Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol. 2009;104:868–872.
42. Fornal M, Wizner B, Cwynar M, et al. Association of red blood cell distribution width, inflammation markers and morphological as well as rheological erythrocyte parameters with target organ damage in hypertension. Clin Hemorheol Micro. 2014;56:325–335.
43. Lobmeyer MT, Wang L, Zineh I, et al. Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive treated patients. Pharmacogenet Genomics. 2011;21:42.
44. Patel SK, Velkoska E, Freeman M, Wai B, Lancefield TF, Burrell LM. From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension. Front Physiol 2014;5:227.
45. Rudnicki M, Mayer G. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. Pharmacogenomics. 2009;10:463–476.
46. Santulli G, Cipolletta E, Sorriento D, et al. CaMK4 gene deletion induces hypertension. J Am Heart Assoc. 2012;1:e001081.
47. Santulli G, Trimarco B, Iaccarino G. G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. High Blood Press Cardiovasc Prev. 2013;20:5–12.